Immunology

Neuroimaging and biomarker evidence of neurodegeneration in asthma



http://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cb2209a0-1d96-4b02-96d2-03b70ddba255/gr3.jpg

    • Peters M.C.
    • McGrath K.W.
    • Hawkins G.A.
    • Hastie A.T.
    • Levy B.D.
    • Israel E.
    • et al.

    Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.

    Lancet Respir Med. 2016; 4: 574-584

    • Rusanen M.
    • Ngandu T.
    • Laatikainen T.
    • Tuomilehto J.
    • Soininen H.
    • Kivipelto M.

    Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study.

    Curr Alzheimer Res. 2013; 10: 549-555

    • Chen M.H.
    • Li C.T.
    • Tsai C.F.
    • Lin W.C.
    • Chang W.H.
    • Chen T.J.
    • et al.

    Risk of dementia among patients with asthma: a nationwide longitudinal study.

    J Am Med Dir Assoc. 2014; 15: 763-767

    • Lutsey P.L.
    • Chen N.
    • Mirabelli M.C.
    • Lakshminarayan K.
    • Knopman D.S.
    • Vossel K.A.
    • et al.

    Impaired lung function, lung disease, and risk of incident dementia.

    Am J Respir Crit Care Med. 2019; 199: 1385-1396

    • Peng Y.H.
    • Wu B.R.
    • Su C.H.
    • Liao W.C.
    • Muo C.H.
    • Hsia T.C.
    • et al.

    Adult asthma increases dementia risk: a nationwide cohort study.

    J Epidemiol Community Health. 2015; 69: 123-128

    • Zhuang T.T.
    • Pan C.
    • Chen J.J.
    • Han F.
    • Zhu X.L.
    • Xu H.
    • et al.

    Chronic asthma–induced behavioral and hippocampal neuronal morphological changes are concurrent with BDNF, cofilin1 and Cdc42/RhoA alterations in immature mice.

    Brain Res Bull. 2018; 143: 194-206

    • Xia M.-X.
    • Ding X.
    • Qi J.
    • Gu J.
    • Hu G.
    • Sun X.-L.

    Inhaled budesonide protects against chronic asthma–induced neuroinflammation in mouse brain.

    J Neuroimmunol. 2014; 273: 53-57

    • Rosenkranz M.A.
    • Busse W.W.
    • Johnstone T.
    • Swenson C.A.
    • Crisafi G.M.
    • Jackson M.M.
    • et al.

    Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation.

    Proc Natl Acad Sci U S A. 2005; 102: 13319-13324

    • Rosenkranz M.A.
    • Busse W.W.
    • Sheridan J.F.
    • Crisafi G.M.
    • Davidson R.J.

    Are there neurophenotypes for asthma? Functional brain imaging of the interaction between emotion and inflammation in asthma.

    PLoS One. 2012; 7e40921

    • Chung K.F.
    • Wenzel S.E.
    • Brozek J.L.
    • Bush A.
    • Castro M.
    • Sterk P.J.
    • et al.

    International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

    Eur Respir J. 2014; 43: 343-373

  • Standardization of spirometry.

    Am J Respir Crit Care Med. 1995; 152: 1107-1136

    • Hoffmeyer F.
    • Raulf-Heimsoth M.
    • Brüning T.

    Exhaled breath condensate and airway inflammation.

    Curr Opin Allergy Clin Immunol. 2009; 9: 16-22

    • Silkoff P.E.
    • Carlson M.
    • Bourke T.
    • Katial R.
    • Ogren E.
    • Szefler S.J.

    The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.

    J Allergy Clin Immunol. 2004; 114: 1241-1256

    • Juniper E.F.
    • Buist A.S.
    • Cox F.M.
    • Ferrie P.J.
    • King D.R.

    Validation of a standardized version of the Asthma Quality of Life Questionnaire.

    Chest. 1999; 115: 1265-1270

    • Johnson R.
    • Wells J.A.
    • Schwarz A.J.
    • Alexander D.C.
    • Zhang H.
    • Holmes H.E.
    • et al.

    Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer’s disease.

    Neuroimage. 2016; 125: 739-744

  • Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI.

    J Magn Reson B. 1996; 111: 209-219

    • Zhang H.
    • Schneider T.
    • Wheeler-Kingshott C.A.
    • Alexander D.C.

    NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain.

    Neuroimage. 2012; 61: 1000-1016

  • Daducci A, Canales-Rodriguez EJ, Zhang H, Dyrby TB, Alexander DC, Thiran JP. Accelerated microstructure imaging via convex optimization (AMICO) from diffusion MRI data. Neuroimage 2014/12/03 2015;105:32-44.

  • Studies of interference in serial verbal reactions.

    J Exp Psychol. 1935; 18: 643-662

    • Lu H.
    • Chan S.S.M.
    • Lam L.C.W.

    “Two-level” measurements of processing speed as cognitive markers in the differential diagnosis of DSM-5 mild neurocognitive disorders (NCD).

    Sci Rep. 2017; 7: 521

    • Gorus E.
    • Raedt R. De
    • Lambert M.
    • Lemper J.
    • Mets T.

    Reaction times and performance variability in normal aging, mild cognitive impairment, and Alzheimer’s disease.

    J Geriatr Psychiatry Neurol. 2008; 21: 204-218

    • Winkler A.M.
    • Webster M.A.
    • Brooks J.C.
    • Tracey I.
    • Smith S.M.
    • Nichols T.E.

    Non-parametric combination and related permutation tests for neuroimaging.

    Hum Brain Mapp. 2016; 37: 1486-1511

    • Winkler A.M.
    • Ridgway G.R.
    • Webster M.A.
    • Smith S.M.
    • Nichols T.E.

    Permutation inference for the general linear model.

    Neuroimage. 2014; 92: 381-397

    • Winkler A.M.
    • Ridgway G.R.
    • Douaud G.
    • Nichols T.E.
    • Smith S.M.

    Faster permutation inference in brain imaging.

    Neuroimage. 2016; 141: 502-516

    • Mayo C.D.
    • Mazerolle E.L.
    • Ritchie L.
    • Fisk J.D.
    • Gawryluk J.R.

    Longitudinal changes in microstructural white matter metrics in Alzheimer’s disease.

    Neuroimage Clin. 2017; 13: 330-338

    • Tu M.C.
    • Lo C.P.
    • Huang C.F.
    • Hsu Y.H.
    • Huang W.H.
    • Deng J.F.
    • et al.

    Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer’s disease and normal ageing.

    PLoS One. 2017; 12: 1-19

    • Passamonti L.
    • Tsvetanov K.A.
    • Jones P.S.
    • Bevan-Jones W.R.
    • Arnold R.
    • Borchert R.J.
    • et al.

    Neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance.

    J Neurosci. 2019; 39: 7218-7226

    • Palmqvist S.
    • Schöll M.
    • Strandberg O.
    • Mattsson N.
    • Stomrud E.
    • Zetterberg H.
    • et al.

    Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.

    Nat Commun. 2017; 8: 1214

    • Brown C.A.
    • Jiang Y.
    • Smith C.D.
    • Gold B.T.

    Age and Alzheimer’s pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities.

    Cortex. 2018; 104: 58-74

    • Lee E.S.
    • Yoo K.
    • Lee Y.B.
    • Chung J.
    • Lim J.E.
    • Yoon B.
    • et al.

    Default mode network functional connectivity in early and late mild cognitive impairment: results from the Alzheimer’s Disease Neuroimaging Initiative.

    Alzheimer Dis Assoc Disord. 2016; 30: 289-296

    • Caballero M.Á.A.
    • Suárez-Calvet M.
    • Duering M.
    • Franzmeier N.
    • Benzinger T.
    • Fagan A.M.
    • et al.

    White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease.

    Brain. 2018; 141: 3065-3080

    • Escartin C.
    • Guillemaud O.
    • Carrillo-de Sauvage M.A.

    Questions and (some) answers on reactive astrocytes.

    Glia. 2019; 67: 2221-2247

    • Abdelhak A.
    • Huss A.
    • Kassubek J.
    • Tumani H.
    • Otto M.

    Serum GFAP as a biomarker for disease severity in multiple sclerosis.

    Sci Rep. 2018; 8: 1-7

    • Watanabe M.
    • Nakamura Y.
    • Michalak Z.
    • Isobe N.
    • Barro C.
    • Leppert D.
    • et al.

    Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.

    Neurology. 2019; 93: E1299-E1311

    • Benussi A.
    • Ashton N.J.
    • Karikari T.K.
    • Gazzina S.
    • Premi E.
    • Benussi L.
    • et al.

    Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration.

    J Alzheimers Dis. 2020; 77: 1129-1141

    • Su W.
    • Chen H.B.
    • Li S.H.
    • Wu D.Y.

    Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson’s disease patients.

    Clin Neurol Neurosurg. 2012; 114: 372-375

    • Preische O.
    • Schultz S.A.
    • Apel A.
    • Kuhle J.
    • Kaeser S.A.
    • Barro C.
    • et al.

    Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease.

    Nat Med. 2019; 25: 277-283

    • Xing L.Y.
    • Yang T.
    • Cui S. Sen
    • Chen G.

    Connexin hemichannels in astrocytes: role in CNS disorders.

    Front Mol Neurosci. 2019; 12: 23

  • Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity.

    Trends Immunol. 2020; 41: 758-770

  • The emerging nature of astrocyte diversity.

    Annu Rev Neurosci. 2019; 42: 187-207

    • Guo R.B.
    • Sun P.L.
    • Zhao A.P.
    • Gu J.
    • Ding X.
    • Qi J.
    • et al.

    Chronic asthma results in cognitive dysfunction in immature mice.

    Exp Neurol. 2013; 247: 209-217

    • Badji A.
    • Sabra D.
    • Bherer L.
    • Cohen-Adad J.
    • Girouard H.
    • Gauthier C.J.

    Arterial stiffness and brain integrity: a review of MRI findings.

    Ageing Res Rev. 2019; 53100907

    • Tattersall M.C.
    • Evans M.D.
    • Korcarz C.E.
    • Mitchell C.
    • Anderson E.
    • DaSilva D.F.
    • et al.

    Asthma is associated with carotid arterial injury in children: the Childhood Origins of Asthma (COAST) cohort.

    PLoS One. 2018; 13: 1-12

    • Steinmann M.
    • Abbas C.
    • Singer F.
    • Casaulta C.
    • Regamey N.
    • Haffner D.
    • et al.

    Arterial stiffness is increased in asthmatic children.

    Eur J Pediatr. 2015; 174: 519-523

    • Tuleta I.
    • Skowasch D.
    • Aurich F.
    • Eckstein N.
    • Schueler R.
    • Pizarro C.
    • et al.

    Asthma is associated with atherosclerotic artery changes.

    PLoS One. 2017; 12: 1-11

    • Silver M.
    • Moore C.M.
    • Villamarin V.
    • Jaitly N.
    • Hall J.E.
    • Rothschild A.J.
    • et al.

    White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study.

    Neuropsychopharmacology. 2018; 43: 1573-1580

    • Chen G.
    • Hu X.
    • Li L.
    • Huang X.
    • Lui S.
    • Kuang W.
    • et al.

    Disorganization of white matter architecture in major depressive disorder: a meta-analysis of diffusion tensor imaging with tract-based spatial statistics.

    Sci Rep. 2016; 6: 1-11

    • Jiskoot L.C.
    • Bocchetta M.
    • Nicholas J.M.
    • Cash D.M.
    • Thomas D.
    • Modat M.
    • et al.

    Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: a cross-sectional diffusion tensor imaging study.

    Ann Clin Transl Neurol. 2018; 5: 1025-1036

    • Yin R.H.
    • Tan L.
    • Liu Y.
    • Wang W.Y.
    • Wang H.F.
    • Jiang T.
    • et al.

    Multimodal voxel-based meta-analysis of white matter abnormalities in Alzheimer’s disease.

    J Alzheimers Dis. 2015; 47: 495-507

    • Duering M.
    • Zieren N.
    • Hervé D.
    • Jouvent E.
    • Reyes S.
    • Peters N.
    • et al.

    Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion–symptom mapping study in CADASIL.

    Brain. 2011; 134: 2366-2375

    • Chou R.C.
    • Kane M.
    • Ghimire S.
    • Gautam S.
    • Gui J.

    Treatment for rheumatoid arthritis and risk of Alzheimer’s disease: a nested case–control analysis.

    CNS Drugs. 2016; 30: 1111-1120

    • Keatings V.M.
    • O’Connor B.J.
    • Wright L.G.
    • Huston D.P.
    • Corrigan C.J.
    • Barnes P.J.

    Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum.

    J Allergy Clin Immunol. 1997; 99: 693-698

    • Koizumi A.
    • Hashimoto S.
    • Kobayashi T.
    • Imai K.
    • Yachi A.
    • Horie T.

    Elevatian of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma.

    Clin Exp Immunol. 1995; 101: 468-473

    • Naji N.
    • Smith S.G.
    • Gauvreau G.M.
    • O’Byrne P.M.

    T helper 17 cells and related cytokines after allergen inhalation challenge in allergic asthmatics.

    Int Arch Allergy Immunol. 2014; 165: 27-34

    • Ramakrishnan R.K.
    • Al Heialy S.
    • Hamid Q.

    Role of IL-17 in asthma pathogenesis and its implications for the clinic.

    Expert Rev Respir Med. 2019; 13: 1057-1068

    • Cipollini V.
    • Anrather J.
    • Orzi F.
    • Iadecola C.

    Th17 and cognitive impairment: possible mechanisms of action.

    Front Neuroanat. 2019; 13: 95

    • Beurel E.
    • Harrington L.E.
    • Jope R.S.

    Inflammatory T helper 17 cells promote depression-like behavior in mice.

    Biol Psychiatry. 2013; 73: 622-630

    • Liu Z.
    • Qiu A.W.
    • Huang Y.
    • Yang Y.
    • Chen J.N.
    • Gu T.T.
    • et al.

    IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson’s disease.

    Brain Behav Immun. 2019; 81: 630-645

  • Interleukin-17A: the key cytokine in neurodegenerative diseases.

    Front Aging Neurosci. 2020; 12: 1-13

    • Calderón-Garcidueñas L.
    • Franco-Lira M.
    • Mora-Tiscareño A.
    • Medina-Cortina H.
    • Torres-Jardón R.
    • Kavanaugh M.

    Early Alzheimer’s and Parkinson’s disease pathology in urban children: friend versus foe responses—it is time to face the evidence.

    Biomed Res Int. 2013; 2013161687

    • Borenstein A.
    • Copenhaver C.
    • Mortimer J.

    Early-life risk factors for Alzheimer disease.

    Alzheimer Dis Assoc Disord. 2006; 20: 63-72

    • Seifan A.
    • Schelke M.
    • Obeng-Aduasare Y.
    • Isaacson R.

    Early life epidemiology of Alzheimer’s disease—a critical review.

    Neuroepidemiology. 2015; : 237-254

    • Luciano R.
    • Barraco G.M.
    • Muraca M.
    • Ottino S.
    • Spreghini M.R.
    • Sforza R.W.
    • et al.

    Biomarkers of Alzheimer disease, insulin resistance, and obesity in childhood.

    Pediatrics. 2015; 135: 1074-1081

  • The “LEARn” (latent early-life associated regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial steps.

    Exp Gerontol. 2010; 45: 291-296

    • Perez-Nievas B.G.
    • Stein T.D.
    • Tai H.C.
    • Dols-Icardo O.
    • Scotton T.C.
    • Barroeta-Espar I.
    • et al.

    Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology.

    Brain. 2013; 136: 2510-2526

    • Heppner F.L.
    • Ransohoff R.M.
    • Becher B.

    Immune attack: the role of inflammation in Alzheimer disease.

    Nat Rev Neurosci. 2015; 16: 358-372

    • Heneka M.T.
    • Kummer M.P.
    • Latz E.

    Innate immune activation in neurodegenerative disease.

    Nat Rev Immunol. 2014; 14: 463-477

    • Karahan E.
    • Costigan A.G.
    • Graham K.S.
    • Lawrence A.D.
    • Zhang J.

    Cognitive and white-matter compartment models reveal selective relations between corticospinal tract microstructure and simple reaction time.

    J Neurosci. 2019; 39: 5910-5921

    • Budisavljevic S.
    • Dell’Acqua F.
    • Zanatto D.
    • Begliomini C.
    • Miotto D.
    • Motta R.
    • et al.

    Asymmetry and structure of the fronto-parietal networks underlie visuomotor processing in humans.

    Cereb Cortex. 2017; 27: 1532-1544

    • Tu M.C.
    • Lo C.P.
    • Huang C.F.
    • Huang W.H.
    • Deng J.F.
    • Hsu Y.H.

    Visual attention performances and related cerebral microstructural integrity among subjects with subjective cognitive decline and mild cognitive impairment.

    Front Aging Neurosci. 2018; 10: 1-13

    • Sisco S.
    • Slonena E.
    • Okun M.S.
    • Bowers D.
    • Price C.

    Parkinson’s disease and the Stroop color word test: processing speed and interference algorithms.

    Clin Neuropsychol. 2016; 30: 1104-1117

    • Phillips M.
    • Rogers P.
    • Haworth J.
    • Bayer A.
    • Tales A.

    Intra-individual reaction time variability in mild cognitive impairment and Alzheimer’s disease: gender, processing load and speed factors.

    PLoS One. 2013; 8e65712

    • Janson C.
    • De Backer W.
    • Gislason T.
    • Plaschke P.
    • Björnsson E.
    • Hetta J.
    • et al.

    Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries.

    Eur Respir J. 1996; 9: 2132-2138

    • Green R.H.
    • Brightling C.E.
    • McKenna S.
    • Hargadon B.
    • Parker D.
    • Bradding P.
    • et al.

    Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

    Lancet. 2002; 360: 1715-1721

    • Lai J.
    • Hu M.
    • Wang H.
    • Hu M.
    • Long Y.
    • Miao M.
    • et al.

    Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42–induced memory impairment and neuroinflammatory and apoptotic responses in mice.

    Neuropharmacology. 2014; 79: 707-714

    • Lai J.
    • Mei Z.L.
    • Wang H.
    • Hu M.
    • Long Y.
    • Miao M.X.
    • et al.

    Montelukast rescues primary neurons against Aβ1-42–induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.

    Neurochem Int. 2014; 75: 26-31

    • Kroll J.L.
    • Steele A.M.
    • Pinkham A.E.
    • Choi C.
    • Khan D.A.
    • Patel S.V.
    • et al.

    Hippocampal metabolites in asthma and their implications for cognitive function.

    Neuroimage Clin. 2018; 19: 213-221

  • Pathology and hippocampal atrophy in Alzheimer’s disease.

    Lancet Neurol. 2017; 16: 862-864

    • Woods C.P.
    • Argese N.
    • Chapman M.
    • Boot C.
    • Webster R.
    • Dabhi V.
    • et al.

    Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

    Eur J Endocrinol. 2015; 173: 633-642

    • Marschallinger J.
    • Schäffner I.
    • Klein B.
    • Gelfert R.
    • Rivera F.J.
    • Illes S.
    • et al.

    Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.

    Nat Commun. 2015; 6: 8466

    • Jang H.
    • Kim S.
    • Lee J.M.
    • Oh Y.S.
    • Park S.M.
    • Kim S.R.

    Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease.

    Neuroreport. 2017; 28: 242-249

    • Grinde B.
    • Schirmer H.
    • Eggen A.E.
    • Aigner L.
    • Engdahl B.

    A possible effect of montelukast on neurological aging examined by the use of register data.

    Int J Clin Pharm. 2021; 43: 541-548

    • Brown E.S.
    • Woolston D.J.
    • Frol A.B.

    Amygdala volume in patients receiving chronic corticosteroid therapy.

    Biol Psychiatry. 2008; 63: 705-709

    • Brown E.S.
    • Woolston D.J.
    • Frol A.
    • Bobadilla L.
    • Khan D.A.
    • Hanczyc M.
    • et al.

    Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.

    Biol Psychiatry. 2004; 55: 538-545

    • Gitelman D.R.
    • Klein-Gitelman M.S.
    • Ying J.
    • Sagcal-Gironella A.C.P.
    • Zelko F.
    • Beebe D.W.
    • et al.

    Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit.

    Arthritis Rheum. 2013; 65: 2190-2200

    • Hájek T.
    • Kopeček M.
    • Preiss M.
    • Alda M.
    • Höschl C.

    Prospective study of hippocampal volume and function in human subjects treated with corticosteroids.

    Eur Psychiatry. 2006; 21: 123-128

    • US Department of Health and Human Services, National Institutes of Health, National Institute on Aging

    2014-2015 Alzheimer’s disease progress report: advancing research toward a cure.

    ()

    • US Department of Health and Human Services
    • Office of the Assistant Secretary for Planning and Evaluation

    National plan to address Alzheimer’s disease: 2015 update.

    ()

  • The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders.

    Trans R Soc Trop Med Hyg. 2007; 101: 1072-1074

    • Raison C.
    • Lowry C.
    • Rook G.

    Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major.

    Arch Gen Psychiatry. 2010; 67: 1211-1224



  • Source link

    Products You May Like

    Articles You May Like

    Tumor elimination requires simultaneous expression of both class I and II neo-epitopes
    2021 Year in Review: Spotlight on Eosinophils
    CDC in Action
    Development and validation of the Exercise-Induced Laryngeal Obstruction Dyspnea Index (EILODI)
    Feds approve military personnel for Spectrum, Beaumont; Northern Michigan hospitals seeking help

    Leave a Reply

    Your email address will not be published. Required fields are marked *